Intervention of Air Pollution and Acute Coronary Syndrome
1 other identifier
interventional
200
1 country
1
Brief Summary
To determine the effect of intervention of ambient air pollution on acute coronary syndrome patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 10, 2019
CompletedFirst Submitted
Initial submission to the registry
October 11, 2019
CompletedFirst Posted
Study publicly available on registry
October 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedSeptember 16, 2021
September 1, 2021
3.7 years
October 11, 2019
September 14, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
vascular function
Systolic blood pressure and diastolic blood pressure measured by omron HBP-1300
six months
autonomic nervous function
Twenty four-hour electrocardiograms and heart rate variability
six months
Study Arms (2)
no masking
SHAM COMPARATORnot wearing facemask
masking
ACTIVE COMPARATORwearing facemask
Interventions
Eligibility Criteria
You may qualify if:
- Non-smoker of any type during past six months and living in a non-smoking household.
- A diagnosis of myocardial infarction or unstable angina 7-90 days prior to signed informed consent.
You may not qualify if:
- Unstable CV disorders including uncompensated heart failure, refractory angina, uncontrolled arrhythmias, critical valvular heart disease and severe hypertension.
- A history of infection with human immunodeficiency virus.
- History of malignancy including leukemia and lymphoma AND/OR any severe, life-threatening disease AND/OR history of drug abuse within the last 2 years.
- Pregnancy or intent to get pregnant during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University ,School of Public Health
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wei Huang, PhD
Peking University Health Science Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 11, 2019
First Posted
October 15, 2019
Study Start
April 10, 2019
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
September 16, 2021
Record last verified: 2021-09